Yuan-yuan P. Zhang

Beijing Key Laboratory Of Hematopoietic Stem Cell Transplantation, P.R. China
Beijing, 100044, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 136 publications

Haploidentical allogeneic haematopoietic stem cell transplantation for paroxysmal nocturnal haemoglobinuria: a retrospective analysis.

Haploidentical allogeneic haematopoietic stem cell transplantation for paroxysmal nocturnal haemoglobinuria: a retrospective analysis.

Journal: Annals of hematology
Published: February 13, 2026

Bone marrow SELENOP+ macrophages support hematopoiesis after transplantation via GAS6-AXL signaling pathway.

Bone marrow SELENOP+ macrophages support hematopoiesis after transplantation via GAS6-AXL signaling pathway.

Journal: Cancer letters
Published: January 21, 2026

Prognostic significance of HLA-B leader matching status and its relationship with NK cell reconstitution in patients with hematological malignancies following haploidentical transplantation.

Prognostic significance of HLA-B leader matching status and its relationship with NK cell reconstitution in patients with hematological malignancies following haploidentical transplantation.

Journal: Cancer letters
Published: November 20, 2025

Desensitization Therapy Using Sirolimus and Anti-CD20 Monoclonal Antibody Based Regimen In Haploidentical Transplant Recipients Positive for Donor-Specific Anti-HLA Antibodies.

Desensitization Therapy Using Sirolimus and Anti-CD20 Monoclonal Antibody Based Regimen In Haploidentical Transplant Recipients Positive for Donor-Specific Anti-HLA Antibodies.

Journal: Transplantation and cellular therapy
Published: November 17, 2025

Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: A national cohort study.

Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: A national cohort study.

Journal: Cancer letters
Published: November 02, 2025

Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial.

Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial.

Journal: Nature communications
Published: October 15, 2025

Empiric Imipenem/Cilastatin/Relebactam for Febrile Neutropenia After Allogeneic Hematopoietic Stem Cell Transplantation: Two Case Reports.

Empiric Imipenem/Cilastatin/Relebactam for Febrile Neutropenia After Allogeneic Hematopoietic Stem Cell Transplantation: Two Case Reports.

Journal: Journal of blood medicine
Published: September 10, 2025

Chronic graft-versus-host disease after haploidentical transplantation in aplastic anemia: clinical characteristics, risk factors, and survival outcomes.

Chronic graft-versus-host disease after haploidentical transplantation in aplastic anemia: clinical characteristics, risk factors, and survival outcomes.

Journal: Bone marrow transplantation
Published: September 07, 2025

Low Dose of IL-2 Application for Graft-Versus-Host Disease Prophylaxis Following Haploidentical Stem Cell Transplantation.

Low Dose of IL-2 Application for Graft-Versus-Host Disease Prophylaxis Following Haploidentical Stem Cell Transplantation.

Journal: MedComm
Published: August 03, 2025

Hematopoiesis could be improved by correcting aberrant bone marrow macrophages polarization in aplastic anemia patients.

Hematopoiesis could be improved by correcting aberrant bone marrow macrophages polarization in aplastic anemia patients.

Journal: Science China. Life sciences
Published: June 23, 2025

Long-Term Efficacy of Epstein-Barr Virus-Specific T Cells for Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation: A Real-World Study.

Long-Term Efficacy of Epstein-Barr Virus-Specific T Cells for Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation: A Real-World Study.

Journal: Transplantation and cellular therapy
Published: June 20, 2025

Safety and Efficacy of Adoptive Transfer of Stem Cell Memory Enriched Virus Specific T Cells against CMV and EBV.

Safety and Efficacy of Adoptive Transfer of Stem Cell Memory Enriched Virus Specific T Cells against CMV and EBV.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 04, 2025
Showing 1-12 of 136

Last Updated: 09/26/2026